gptkbp:instance_of
|
gptkb:Spider-Man
|
gptkbp:administered_by
|
gptkb:healthcare_professionals
patients
|
gptkbp:approves
|
gptkb:1981
gptkb:FDA
|
gptkbp:atccode
|
R03 AC02
|
gptkbp:available_on
|
generic
|
gptkbp:can_be_used_with
|
gptkb:Android
anticholinergics
|
gptkbp:clinical_trial
|
Phase III
|
gptkbp:contraindication
|
hypersensitivity to albuterol
|
gptkbp:dosage_form
|
metered-dose inhaler
solution for nebulization
|
gptkbp:formulation
|
gptkb:Spider-Man
nebulizer solution
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ventolin
|
gptkbp:ingredients
|
albuterol
exercise-induced bronchospasm
|
gptkbp:is_associated_with
|
increased exercise tolerance
improved lung function
reduced wheezing
|
gptkbp:is_available_in
|
liquid form
tablet form
various strengths
|
gptkbp:is_compared_to
|
placebo
other bronchodilators
|
gptkbp:is_considered
|
first-line treatment for COPD
first-line treatment for asthma
rescue medication
|
gptkbp:is_designed_to
|
long-term control
|
gptkbp:is_evaluated_by
|
clinical studies
|
gptkbp:is_involved_in
|
gptkb:children
adults
|
gptkbp:is_part_of
|
respiratory therapy
asthma management plan
|
gptkbp:is_recommended_for
|
COPD exacerbations
acute asthma symptoms
|
gptkbp:is_subject_to
|
prescription regulations
|
gptkbp:is_used_in
|
emergency situations
pediatric patients
adult patients
|
gptkbp:manufacturer
|
gptkb:Glaxo_Smith_Kline
|
gptkbp:marketed_as
|
gptkb:Ventolin_HFA
gptkb:Pro_Air
gptkb:Proventil
|
gptkbp:mechanism_of_action
|
beta-2 adrenergic agonist
|
gptkbp:packaging
|
aerosol canister
|
gptkbp:route_of_administration
|
inhalation
|
gptkbp:shelf_life
|
3 years
|
gptkbp:side_effect
|
headache
nervousness
tremors
palpitations
|
gptkbp:storage
|
room temperature
|
gptkbp:structure
|
C13 H21 N
|
gptkbp:suitable_for
|
severe asthma attacks without medical supervision
|
gptkbp:used_for
|
gptkb:asthma
chronic obstructive pulmonary disease
|
gptkbp:bfsParent
|
gptkb:Alberto_Balsalm
gptkb:Drukqs
|
gptkbp:bfsLayer
|
6
|